Rays of Belief Ltd, a specialist provider of neuro‑developmental services, announced that it will list on the stock exchanges on September 1. The IPO will be offered through a book‑building process and is expected to raise around ₹2,500 crore, according to the prospectus. The company, which operates a network of therapy centres across major metros, is positioning itself as a fast‑growing player in the health‑care sector that has been a beneficiary of rising disposable incomes and increased awareness of early childhood disorders. The proceeds are earmarked for an aggressive rollout of 319 new centres by the end of fiscal year 2029, focusing on Tier‑II and Tier‑III cities where demand for specialised neuro‑care is still nascent.
Management also highlighted plans to upgrade existing facilities with digital diagnostics and tele‑therapy platforms, signalling a shift towards technology‑enabled care. Revenue has reportedly grown at a compound annual rate of over 30 % in the last three years, giving the firm a solid financial base for expansion. When the filing was made, the Nifty Health‑Care index was trading near record highs, and analysts expect the listing to add fresh momentum to the sector’s rally. The Sensex, which has been buoyed by strong earnings in health‑care stocks, could see a modest uptick if the IPO is well‑received.
Retail investors are being advised to assess the pricing, the company’s earnings visibility and the competitive landscape before committing funds. For salaried professionals looking to diversify, the Rays of Belief IPO offers exposure to a niche growth story within a defensive sector. However, the typical IPO risks – such as price volatility in the early trading days and the need for sustained demand in smaller cities – remain. Investors should weigh the long‑term growth potential against these uncertainties before allocating capital.